Breaking newsEAN NewsCOVID-19Research
The cognitive consequences of the COVID-19 epidemic: collateral damage?
The cognitive consequences of the COVID-19 epidemic: collateral damage?
The European Parliament marked Brain Health Day: Prevention, Policy, Progress with a high‑level programme hosted by MEP Angelika Winzig, bringing renewed political attention to Europe’s urgent need for an integrated brain health strategy.
Latest Posts
-
-
Breaking newsEAN NewsCOVID-19ResearchDeath Rate Due to COVID-19 in Alzheimer’s Disease and Frontotemporal Dementia
Death Rate Due to COVID-19 in Alzheimer's Disease and Frontotemporal Dementia -
Breaking newsEAN NewsCOVID-19
Cerebral venous sinus thrombosis associated with SARS-CoV-2; a multinational case series
Cerebral venous sinus thrombosis associated with SARS-CoV-2; a multinational case series -
Breaking newsEAN NewsCOVID-19Research
Immunology of COVID-19 and disease-modifying therapies: the good, the bad and the unknown
Immunology of COVID-19 and disease-modifying therapies: the good, the bad and the unknown -
Breaking newsEAN NewsCOVID-19Research
Neurotropism of SARS-CoV-2 and its neuropathological alterations: Similarities with other coronaviruses
Neurotropism of SARS-CoV-2 and its neuropathological alterations: Similarities with other coronaviruses -
Breaking newsEAN NewsCOVID-19Research
CSF biomarkers in patients with COVID-19 and neurological symptoms A case series
CSF biomarkers in patients with COVID-19 and neurological symptoms A case series -
Breaking newsEAN NewsCOVID-19Research
COVID-19 impact on consecutive neurological patients admitted to the emergency department
COVID-19 impact on consecutive neurological patients admitted to the emergency department -
Considerations for diagnostic COVID-19 tests
-
Breaking newsEAN NewsCOVID-19ResearchDisease burden and clinical severity of the first pandemic wave of COVID-19 in Wuhan, China
Disease burden and clinical severity of the first pandemic wave of COVID-19 in Wuhan, China -
Virology, transmission, and pathogenesis of SARS-CoV-2
-
Breaking newsEAN NewsCOVID-19ResearchConvalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial)
Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial) -
This year’s Annual Pain Forum was organised online due to the COVID-19 pandemic. -
Breaking newsEAN NewsCOVID-19Research
Neuropathology of patients with COVID-19 in Germany: a post-mortem case series
Neuropathology of patients with COVID-19 in Germany: a post-mortem case series -
Breaking newsEAN NewsCOVID-19Research
Lopinavir–ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Lopinavir–ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial -
Breaking newsEAN NewsCOVID-19Research
Prevalence, management, and outcomes of SARS-CoV-2 infections in older people and those with dementia in mental health wards in London, UK: a retrospective observational study
Prevalence, management, and outcomes of SARS-CoV-2 infections in older people and those with dementia in mental health wards in London, UK: a retrospective observational study